Inflammatory Bowel Disease Clinical Trial
Official title:
Telomere Repair Gene Mutations in Inflammatory Bowel Disease
NCT number | NCT00353639 |
Other study ID # | 060082 |
Secondary ID | 06-H-0082 |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | May 15, 2006 |
Est. completion date | May 21, 2020 |
Verified date | May 2020 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study will evaluate and compare the genes of the telomere repair complex in healthy
control subjects, patients with blood diseases, and patients with inflammatory bowel disease
to identify what, if any, changes are associated specifically with inflammatory bowel
disease.
Patients between 2 and 80 years of age with ulcerative colitis or regional enteritis may be
eligible for this study. Participants are recruited from the practice of Dr. Stuart
Danovitch, Washington, D.C.
Researchers have established that minor differences in a specific set of genes called the
telomere repair complex are related to immune-mediated diseases of the bone marrow. NIH
researchers are now interested in whether inflammatory bowel disease and other autoimmune
diseases show a similar pattern of genetic differences.
Participants provide a cell sample for evaluation of the telomere repair complex. The sample
is collected via buccal swab, a gentle scraping of the inside of the cheek, and stored for
use in research.
Status | Completed |
Enrollment | 95 |
Est. completion date | May 21, 2020 |
Est. primary completion date | May 15, 2006 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 2 Years to 80 Years |
Eligibility |
- INCLUSION CRITERIA: Diagnosis of ulcerative colitis or regional enteritis For adults: Ability to comprehend the investigational nature of the study and provide informed consent. Or For minors: Written informed consent from one parent or guardian and informed assent. The process will be explained to the minor on a level of complexity appropriate for their age and ability to comprehend. Age greater than 2 but less or equal to 80 years old EXCLUSION CRITERIA: All subjects not fulfilling the inclusion criteria will be considered ineligible. |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Heart, Lung, and Blood Institute (NHLBI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To identify if telomere repair complex gene mutations are abnormally prevalent among patients with IBO. | To identify if telomere repair complex gene mutations are abnormally prevalent among patients with IBO. | Ongoing | |
Secondary | To correlate telomere repair gene mutations in subjects with immune mediated disease stratified based on diagnosis as they relate to clinical course and response to therapy. | We aim to correlate telomere repair gene mutations in subjects with immune mediated disease stratified based on diagnosis with clinical course and response to therapy. | Ongoing | |
Secondary | To compare the telomere repair gene mutations of normal individuals (from large populations studies in the public domain) as well as to those of patients with known bone marrow failure | We aim to compare the telomere repair gene mutations of normal individuals with those of patients with known bone marrow failure | Ongoing |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03278912 -
Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
|
||
Terminated |
NCT00061282 -
Clotrimazole Enemas for Pouchitis in Children and Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT05579392 -
A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis
|
N/A | |
Completed |
NCT03264690 -
Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients
|
||
Recruiting |
NCT02861053 -
Inflammatory Bowel Disease : Could a Regular Physical Activity Reduce Patients Fatigue ?
|
N/A | |
Recruiting |
NCT02275676 -
Resting Energy Expenditure and Nutritional Status in IBD
|
N/A | |
Completed |
NCT02503696 -
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
|
N/A | |
Completed |
NCT02197780 -
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
|
N/A | |
Completed |
NCT02161640 -
Vascular Dysfunction in Paediatric IBD
|
N/A | |
Completed |
NCT01852760 -
Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound
|
N/A | |
Completed |
NCT01860651 -
Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease
|
N/A | |
Completed |
NCT01933867 -
Water-aided Colonoscopy in Inflammatory Bowel Disease Patients
|
N/A | |
Completed |
NCT01676324 -
FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD)
|
N/A | |
Completed |
NCT01666535 -
Infliximab IBD Influenza Vaccine Study
|
N/A | |
Completed |
NCT01692743 -
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
|
Phase 3 | |
Completed |
NCT01688557 -
Trial on Innovative Technologies in Colonoscopy
|
N/A | |
Completed |
NCT01557387 -
Real-time Diagnosis of Pseudopolyps During Colonoscopy
|
||
Completed |
NCT01981616 -
Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab
|
Phase 1 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT01221818 -
A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects
|
Phase 1 |